Menu

Calidi Biotherapeutics, Inc. CLDI

Full chart Compare
Set alert

Price alert · CLDI

All alert types
0.73 USD +0.03 (+4.71%)

At closeNov 9, 2026, 7:50 PM EST

0.73 0.00 0.00%

After hours · Nov 9, 7:50 PM ET

0.67305 Day range 0.765
0.64 52-week range 24.64
YTD
-96.08%
1 year
-96.80%

Revenue & Expenses

Net Loss → Expenses: $25.43MExpenses → Gross Loss: $229.00KExpenses → Selling, General & Admin: $15.64MExpenses → Research & Development: $7.26MExpenses → Interest Expense: $158.00KExpenses → Other Expenses: $2.13MExpenses → Income Tax: $11.00KRevenue → Cost of Revenue: $45.00KNet Loss$25.43MCost of Revenue$274.00KExpenses$25.43MGross Loss$229.00KSelling, General & Admin$15.64MResearch & Development$7.26MInterest Expense$158.00KOther Expenses$2.13MIncome Tax$11.00KRevenue$45.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

CLDI annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-20.24M-21.78M-28.99M-23.13M-10.48M
-19.91M-22.14M-29.22M-25.43M-10.93M
-95.00-571.00-3,327.00-5,741.00-1,056.00
CLDI annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
5.60M9.59M1.95M372.00K2.14M
8.86M14.18M10.02M2.60M3.39M
5.10M12.21M18.25M43.44M26.00M
2.56M7.04M7.24M35.18M20.99M
3.76M1.53M-8.23M-50.44M-31.61M
CLDI annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-21.29M-19.69M-26.98M-13.21M-7.77M
-170.00K-16.00K-478.00K-494.00K-215.00K
17.46M27.36M29.04M12.09M9.81M
-120.00K-16.00K-585.00K-428.00K-206.00K
-3.99M7.64M1.58M-1.65M1.82M